Advertisement

Topics

MP Phase.com Company Profile

05:32 EST 10th December 2018 | BioPortfolio

MPPhase.com in a non-commercial web site created in January 2004.Since the beginning of his creation, MPPhase is a web site on continuing improvement and progress. After Freelance CRA and Local CRO, we have added information about Medical Writer, Translator, Vendor and soon on Pharmaceutical Training. In November 2004, we inserted news related to medical research in order to render our web site more attractive. We have just worked on inserting data regarding Regulatory Affairs Consultants.We really hope MPPhase is an adding value for all persons involved in clinical research. We also hope to become a reference on the web and on the pharmaceutical research field.

Contact

Phone: 1 801-537-7800
Fax: 1 801-537-7805
Email: info@allencomm.com


News Articles [872 Associated News Articles listed on BioPortfolio]

Biofrontera: "Heiße Phase" startet

Mit dem Start der Patientenrekrutierung hat die "heiße Phase" für eine klinische Studie der dritten Phase von Biofrontera in den USA begonnen. Das Unternehmen aus Leverkusen will im Rahmen der Stud....

Phase I Gives Hope for First Zika Vaccine

Results from a Phase I trial showed promising safety and efficacy of a potential first vaccine against the mosquito-borne Zika virus, developed by French biotech Valneva and US biopharma Emergent BioS...

Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3 Global Registrational Trial of Bemarituzumab

Five Prime Therapeutics (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that the company completed the Phase 1 safety...

Basilea doses first patient in Phase lla study of BAL101553

Switzerland-based Basilea Pharmaceutica has dosed the first patient in the Phase lla expansion part of a Phase l/lla clinical trial...Read More... The post Basilea doses first patient in Phase lla stu...

Ovid Therapeutics Plans to Move into the Phase 3 Trial Based on End-of-Phase 2 Meeting for OV101

Ovid Therapeutics (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced plans to move ahead w...

Genkyotex Provides Update on PBC Phase 2 Trial and Reports June 30, 2018, Cash Position

Ongoing enrollment in Phase 2 trial of GKT831 in Primary Biliary Cholangitis (PBC) has reached 75% of the total number of patients First DSMB meeting for Phase 2 study of GKT831 in PBC successfull...

Cantargia: Phase I Safety Evaluation Part of CANFOUR Trial of Antibody CAN04 Completed and Phase IIa Part Being Initiated

STOCKHOLM, Dec 7, 2018 /PRNewswire/ -- Cantargia AB (publ) today announces that all patients in the phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of ...

Galapagos NV: GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS

-- EQUATOR Achieves Primary Endpoint of ACR20 Response at Week 16 -- -- Galapagos to Receive $15 Million Payment from Gilead for Progression into Phase 3 of the Phase 2b/3 SELECTION Study of Filgo...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Granisetron hydrochloride [Breckenridge Pharmaceutical, Inc.]

GRANISETRON HYDROCHLORIDE TABLETS, USP

Sprycel [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use SPRYCEL safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) Tablet for Oral Use Initial U.S. App...

Temodar [Schering Corporation]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

Temodar [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

Nicardipine hydrochloride [Sandoz Inc. ]

Rx only

PubMed Articles [1340 Associated PubMed Articles listed on BioPortfolio]

Formation of lead ferrites for immobilizing hazardous lead into iron-rich ceramic matrix.

A strategy of immobilizing lead in the framework of ferrite-ceramic matrix, to reduce its environmental hazard was explored in this study. The mechanisms of incorporating lead into lead ferrites (δ-p...

Fast and accurate wavefront reconstruction in two-frame phase-shifting interferometry with unknown phase step.

A fast and accurate wavefront reconstruction method for two-frame phase-shifting interferometry is proposed. The unknown phase step between the two interferograms is estimated directly by solving a qu...

A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III.

Conventionally, evaluation of a new drug, A, is done in three phases. Phase I is based on toxicity to determine a \maximum tolerable dose" (MTD) of A, phase II is conducted to decide whether A at the ...

Simple-structured, subfemtosecond-resolution optical-microwave phase detector.

We demonstrate a simple all-fiber photonic phase detector that can measure the phase (timing) difference between an optical pulse train and a microwave signal with subfemtosecond resolution and -60 ...

Improved phase-attenuation duality method with space-frequency joint domain iterative regularization.

A common problem of in-line phase contrast imaging systems based on laboratory source and detector is the negative effects of finite source size, limited spatial resolution, and system noise. These ne...

Clinical Trials [1397 Associated Clinical Trials listed on BioPortfolio]

Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)

This multi-centre, non-randomized open phase I/randomized phase II study will be conducted in 70 patients (10 in phase I, 60 in phase II) with platinum-refractory recurrent epithelial canc...

A Phase I/II Study of Regorafenib Plus Avelumab in Digestive Tumors

Assessment of the efficacy and safety of Regorafenib and Avelumab in four cohorts of patients with advanced or metastatic digestive solid tumors (four cohorts), once the Recommanded Phase ...

Pharmacotherapy of Treatment-Resistant Mania

Verapamil has been found in some but not all studies to have antimanic activity. Therefore, we investigated the use of verapamil, alone or as an adjunctive treatment, in manic patients wh...

Tinostamustine Conditioning and Autologous Stem Cell

Phase 1 The primary objectives of Phase 1 of this study are to: Establish the safety, toxicity, and maximum tolerated dose (MTD) of the tinostamustine conditioning regimen. ...

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

This study is composed of Phase I and Phase II part. Phase I part: The objective is to evaluate the safety of BMS-354825 in subject with chronic phase Chronic Myelogenous Leukemia (CML)....

Companies [798 Associated Companies listed on BioPortfolio]

Phase One Medical, L.L.C.

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage development and small part design and manufacture. For...

Phase One Medical

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage device development and small part design and manufactu...

Chiltern

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad rang...

iResearch

iResearch is a specialist Clinical Research Resourcing organisation providing a tailored management outsourcing service for the provision of interim medical, clinical and technical staff. The expertis...

Clinical Network Services (CNS)

Clinical Network Services (CNS) Pty Ltd is an Australian CRO, focused on providing full contract research organisational clinical trial services to the international healthcare community particularly ...

More Information about "MP Phase.com" on BioPortfolio

We have published hundreds of MP Phase.com news stories on BioPortfolio along with dozens of MP Phase.com Clinical Trials and PubMed Articles about MP Phase.com for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MP Phase.com Companies in our database. You can also find out about relevant MP Phase.com Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...


Corporate Database Quicklinks



Searches Linking to this Company Record